MLchartDataset catalogue

ABT-263

Term · Oncology and biomedicine · MLC-T-ONC-000117

A substance being studied in the treatment of lymphomas and other types of cancer. It blocks some of the enzymes that keep cancer cells from dying. It is a type of Bcl-2 family inhibitor. Also called navitoclax.

Table 1. Record
IdentifierMLC-T-ONC-000117
FieldOncology and biomedicine
Expansionsnavitoclax
ReferencesNCI Dictionary of Cancer Terms
Record as JSON 
{
  "id": "MLC-T-ONC-000117",
  "term": "ABT-263",
  "field": "Oncology and biomedicine",
  "definition": "A substance being studied in the treatment of lymphomas and other types of cancer. It blocks some of the enzymes that keep cancer cells from dying. It is a type of Bcl-2 family inhibitor. Also called navitoclax.",
  "expansions": [
    "navitoclax"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/abt-263/"
}

Record 197 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.